UOTTAIMCU
COGT icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Cogent Biosciences COGT Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
+7,488
New +$262K 0.03% 139

Other funds holding COGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s COGT Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Cogent Biosciences (COGT) in Q2 2026: 7,488 shares worth $290K. The stake represents 0.03% of the portfolio and ranks #139 among its holdings.

143 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 7,488 shares of Cogent Biosciences worth $290K as of Q2 2026.
  • Cogent Biosciences was a new University of Texas/Texas AM Investment Management Co (UTIMCO) position in Q2 2026.
  • Cogent Biosciences made up 0.03% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #139 holding.
  • 143 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.